Lesson plan

Avecia

Avecia, a part of Nitto Denko Inc., is a private biotechnology company focused on oligonucleotide production. Avecia has two facilities, one near Boston, MA, and the second in Cincinnati, OH. In 2009, Avecia Biologics Limited based in Billingham, UK was acquired by Merck and was later part of Fujifilm Diosynth Biotechnologies. In 2016, Avecia acquired the assets of Irvine Pharmaceutical Services and Avrio Biopharmaceuticals. Avecia was organized with a biologics business line and the oligonucleotide business line.

Back to article

Article summary

Avecia, a part of Nitto Denko Inc., is a private biotechnology company focused on oligonucleotide production. Avecia has two facilities, one near Boston, MA, and the second in Cincinnati, OH. In 2009, Avecia Biologics Limited based in Billingham, UK was acquired by Merck and was later part of Fujifilm Diosynth Biotechnologies. In 2016, Avecia acquired the assets of Irvine Pharmaceutical Services and Avrio Biopharmaceuticals. Avecia was organized with a biologics business line and the oligonucleotide business line.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.